csirt@kutim:~/threat-intel/cve/CVE-2026-80347

Katalog CVE

CVSS 7.5 · High EPSS 0,35%

Kerentanan Server-Side Request Forgery (SSRF). Skor CVSS 3.1 7.5 (High) menurut vulncheck.com.

Deskripsi (NVD)

mcp-fetch checks a fetch target against its SSRF guard without removing the brackets that surround an IPv6 literal. isSafeUrl reads the hostname from the parsed URL, which for a literal such as http://[::1]/ yields the bracketed string, and then tests it with net.isIP. That call returns zero for a bracketed value, so the branch holding the private-address checks is skipped entirely. The guard falls back to resolving the hostname, the bracketed string is not a resolvable name, no addresses are returned, and the target is reported safe. The HTTP client then strips the brackets and connects. Because the address may be given in IPv4-mapped form, the same path reaches any IPv4 target the loopback and private checks were meant to exclude, including link-local metadata endpoints. isPrivateIPv6 also has no case for the ::ffff: prefix, so the mapped form would still pass even if the brackets were removed. The fetch target is supplied as a tool argument, so an attacker who can influence what the model requests can read internal responses back into the model context.

Rincian

Terbit di NVD
26 Agustus 2026
Terakhir diubah
24 September 2026
Status NVD
Deferred
CVSS 3.1
7.5 (High), sumber vulncheck.com
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-918: Server-Side Request Forgery (SSRF)
EPSS (30 hari)
0,35% peluang dieksploitasi; lebih tinggi dari 26,9% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.